A ASTEX PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, October 13, 2011, a trademark application was filed for A ASTEX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the A ASTEX PHARMACEUTICALS trademark a serial number of 85979327. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, August 28, 2023. This trademark is owned by Astex Pharmaceuticals, Inc.. The A ASTEX PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals

Research and development services in the field of pharmaceuticals; providing medical and scientific health care research information in the field of pharmaceuticals and clinical trials; drug discovery services; biotechnology research; scientific research and analysis in the field of drug discovery and pharmaceutical drug development
a astex pharmaceuticals

General Information

Serial Number85979327
Word MarkA ASTEX PHARMACEUTICALS
Filing DateThursday, October 13, 2011
Status800 - REGISTERED AND RENEWED
Status DateMonday, August 28, 2023
Registration Number4381344
Registration DateTuesday, August 6, 2013
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 25, 2012

Trademark Statements

Description of MarkThe mark consists of a stylized letter "A" with the stylized words "ASTEX PHARMACEUTICALS" appearing to the right. The gray tones are to indicate shading.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals
NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesResearch and development services in the field of pharmaceuticals; providing medical and scientific health care research information in the field of pharmaceuticals and clinical trials; drug discovery services; biotechnology research; scientific research and analysis in the field of drug discovery and pharmaceutical drug development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 19, 2011
Primary Code042
First Use Anywhere DateMonday, September 12, 2011
First Use In Commerce DateSunday, December 4, 2011
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 19, 2011
Primary Code044
First Use Anywhere DateMonday, September 12, 2011
First Use In Commerce DateSunday, December 4, 2011

Trademark Owner History

Party NameASTEX THERAPEUTICS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressCAMBRIDGE CB40QA
GB
Party NameAstex Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588
Party NameAstex Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin, CA 94568
Party NameAstex Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin, CA 94568

Trademark Events

Event DateEvent Description
Monday, October 17, 2011NEW APPLICATION ENTERED
Wednesday, October 19, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 1, 2012ASSIGNED TO EXAMINER
Tuesday, February 7, 2012PRIORITY ACTION WRITTEN
Tuesday, February 7, 2012NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, February 7, 2012PRIORITY ACTION E-MAILED
Friday, August 3, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 3, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 4, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 9, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 16, 2012ASSIGNED TO LIE
Monday, August 20, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 5, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 25, 2012PUBLISHED FOR OPPOSITION
Tuesday, September 25, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 17, 2013TEAS STATEMENT OF USE RECEIVED
Friday, May 17, 2013TEAS REQUEST TO DIVIDE RECEIVED
Friday, May 17, 2013DIVISIONAL REQUEST RECEIVED
Friday, May 17, 2013USE AMENDMENT FILED
Tuesday, May 21, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 4, 2013DIVISIONAL PROCESSING COMPLETE
Tuesday, June 4, 2013STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 5, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, August 6, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, June 25, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, June 29, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, July 2, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 11, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 11, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, July 23, 2019TEAS SECTION 8 & 15 RECEIVED
Sunday, September 1, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, September 1, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, September 1, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 6, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, August 6, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, February 7, 2023TEAS SECTION 8 & 9 RECEIVED
Thursday, August 24, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 28, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, August 28, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, August 28, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, January 10, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, August 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 22, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, November 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

pharmaceuticals astex research field drug discovery development providing scientific services information